IP Library › Granted Patent US 12,232,826
Granted Patent B2
US 12,232,826 · App. 17/846,973 · Granted Feb 25, 2025

Medical device magnetizer system with indicators

Inventors: Steffan Sowards (Salt Lake City, UT); Anthony K. Misener (Bountiful, UT); William Robert McLaughlin (Bountiful, UT)
Assignee: Bard Access Systems, Inc.
A61B34/20A61B90/98H01F13/00A61B2017/00876A61B17/3403A61B2034/2051A61M25/0127
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,232,826
App. No.
17/846,973
Filed
Jun 22, 2022
Granted
Feb 25, 2025
Kind
B2
Art Unit
2838
USPC
361/143
Abstract

A magnetizer system for use with a medical device including ferrous elements. The magnetizer can include a magnetizer body defining a cavity, the magnetizer body having a body opening in communication with the cavity, the magnetizer body including one or more magnets configured to generate a magnetic field configured to imprint a magnetic signature on ferrous elements within the cavity. The magnetizer can include one or more mechanisms configured to detect the presence of the medical device.

Claims (44)

1. A magnetizer system for use with a medical device including ferrous elements, the magnetizer system comprising:

a magnetizer having a magnetizer body defining a cavity, the magnetizer body having a body opening in communication with the cavity, the magnetizer body including one or more magnets configured to generate a magnetic field configured to imprint a magnetic signature on the ferrous elements within the cavity, the magnetic signature configured to differentiate the medical device from other medical devices, wherein the magnetic signature includes a monopole magnetic signature; and

one or more mechanisms configured to detect a presence of the medical device.

2. The magnetizer system according to claim 1 , wherein the one or more mechanisms include an infrared detection system having one or more infrared emitters configured to generate an infrared beam across the cavity and one or more infrared sensors configured to detect the infrared beam, the one or more infrared emitters, and the one or more infrared sensors in communication with a console.

3. The magnetizer system according to claim 2 , wherein the magnetizer includes one or more sensors in communication with the console, the one or more sensors configured to detect and track the medical device using inductive sensing or optical sensing.

4. The magnetizer system according to claim 2 , wherein the console includes one or more processors, an energy source, a non-transitory computer-readable medium, and a plurality of logic modules.

5. The magnetizer system according to claim 4 , wherein the one or more magnets include one or more electromagnets in communication with the energy source.

6. The magnetizer system according to claim 4 , wherein the console is in wireless communication with one or more computing devices or an electronic medical record system.

7. The magnetizer system according to claim 4 , wherein the plurality of logic modules, when executed by the one or more processors, are configured to perform operations including:

activating the one or more infrared sensors and the one or more infrared emitters;

detecting an RFID tag of the medical device;

detecting the infrared beam from the one or more infrared emitters;

activating the one or more infrared sensors; and

detecting the medical device using the one or more infrared sensors by inductive sensing or optical sensing.

8. The magnetizer system according to claim 1 , wherein the one or more mechanisms include a mechanical switch configured to transition between a non-magnetized configuration and a magnetized configuration.

9. The magnetizer system according to claim 8 , wherein the mechanical switch includes a hinge coupled to each of the mechanical switch and a lever arm, the lever arm protruding into the cavity and configured to be contacted by the medical device to transition the mechanical switch from the non-magnetized configuration to the magnetized configuration.

10. The magnetizer system according to claim 9 , wherein the mechanical switch resides within a recess within the magnetizer body.

11. The magnetizer system according to claim 10 , wherein the non-magnetized configuration includes the mechanical switch perpendicular to the lever arm and residing fully within the recess.

12. The magnetizer system according to claim 10 , wherein the magnetized configuration includes the mechanical switch moved away from the recess and the magnetizer body.

13. The magnetizer system according to claim 1 , wherein the magnetizer includes a RFID reader coupled to the magnetizer body or contained within the cavity, the RFID reader in communication with a console.

14. The magnetizer system according to claim 13 , wherein the medical device includes a RFID tag configured to be detected by the RFID reader.

15. The magnetizer system according to claim 1 , wherein the medical device including the ferrous elements is selected from the group consisting of a needle, a catheter, and combinations thereof.

16. The magnetizer system according to claim 1 , wherein the magnetic signature includes one or more of model name, model number, dimensional information, manufacturing information, and serial number.

17. A magnetizer system for use with a medical device including ferrous elements, the magnetizer system comprising:

a magnetizer having a magnetizer body defining a cavity, the magnetizer body having a body opening in communication with the cavity, the magnetizer body including one or more magnets configured to generate a magnetic field configured to imprint a magnetic signature on the ferrous elements within the cavity, the magnetic signature configured to differentiate the medical device from other medical devices; and

one or more mechanisms configured to detect a presence of the medical device, wherein the one or more mechanisms include an infrared detection system having one or more infrared emitters configured to generate an infrared beam across the cavity and one or more infrared sensors configured to detect the infrared beam, the one or more infrared emitters, and the one or more infrared sensors in communication with a console.

18. The magnetizer system according to claim 17 , wherein the magnetizer includes one or more sensors in communication with the console, the one or more sensors configured to detect and track the medical device using inductive sensing or optical sensing.

19. The magnetizer system according to claim 17 , wherein the console includes one or more processors, an energy source, a non-transitory computer-readable medium, and a plurality of logic modules.

20. The magnetizer system according to claim 19 , wherein the one or more magnets include one or more electromagnets in communication with the energy source.

21. The magnetizer system according to claim 19 , wherein the console is in wireless communication with one or more computing devices or an electronic medical record system.

22. The magnetizer system according to claim 19 , wherein the plurality of logic modules, when executed by the one or more processors, are configured to perform operations including:

activating the one or more infrared sensors and the one or more infrared emitters;

detecting an RFID tag of the medical device;

detecting the infrared beam from the one or more infrared emitters;

activating the one or more infrared sensors; and

detecting the medical device using the one or more infrared sensors by inductive sensing or optical sensing.

23. A magnetizer system for use with a medical device including ferrous elements, the magnetizer system comprising:

a magnetizer having a magnetizer body defining a cavity, the magnetizer body having a body opening in communication with the cavity, the magnetizer body including one or more magnets configured to generate a magnetic field configured to imprint a magnetic signature on the ferrous elements within the cavity, the magnetic signature configured to differentiate the medical device from other medical devices; and

one or more mechanisms configured to detect a presence of the medical device, wherein the one or more mechanisms include a mechanical switch configured to transition between a non-magnetized configuration and a magnetized configuration.

24. The magnetizer system according to claim 23 , wherein the mechanical switch includes a hinge coupled to each of the mechanical switch and a lever arm, the lever arm protruding into the cavity and configured to be contacted by the medical device to transition the mechanical switch from the non-magnetized configuration to the magnetized configuration.

25. The magnetizer system according to claim 24 , wherein the mechanical switch resides within a recess within the magnetizer body.

26. A magnetizer system for use with a medical device including ferrous elements, the magnetizer system comprising:

a magnetizer having a magnetizer body defining a cavity, the magnetizer body having a body opening in communication with the cavity, the magnetizer body including one or more magnets configured to generate a magnetic field configured to imprint a magnetic signature on the ferrous elements within the cavity, the magnetic signature configured to differentiate the medical device from other medical devices, wherein the magnetic signature includes one or more of model name, model number, dimensional information, manufacturing information, and serial number; and

one or more mechanisms configured to detect a presence of the medical device.

Continuity (2)
Provisional Application 63213539 · Jun 22, 2021
Related Publication 20220401158A1 · Dec 22, 2022
References Cited (173)
US 3409853A · Guerth · 1968 [cited by applicant]
US 3467926A · Smith · 1969 [cited by applicant]
US 3847157A · Caillouette et al. · 1974 [cited by applicant]
US 4063561A · McKenna · 1977 [cited by applicant]
US 4161943A · Nogier · 1979 [cited by applicant]
US 4237518A · Krulwich · 1980 [cited by applicant]
US 4458705A · Cawood · 1984 [cited by applicant]
US 4529954A · Steingroever et al. · 1985 [cited by applicant]
US 4633237A · Tucknott · 1986 [cited by examiner]
US 5055813A · Johnson · 1991 [cited by applicant]
US 5659279A · Janssen et al. · 1997 [cited by applicant]
US 5803089A · Ferre et al. · 1998 [cited by applicant]
US 5845646A · Lemelson · 1998 [cited by applicant]
US 6154352A · Atallah · 2000 [cited by applicant]
US 6249199B1 · Liu · 2001 [cited by applicant]
US 6310532B1 · Santa Cruz et al. · 2001 [cited by applicant]
US 6432036B1 · Kim · 2002 [cited by applicant]
US 7023309B2 · Laskaris et al. · 2006 [cited by applicant]
US 7090639B2 · Govari · 2006 [cited by applicant]
US 7135978B2 · Gisselberg et al. · 2006 [cited by applicant]
US 7214191B2 · Stringer et al. · 2007 [cited by applicant]
US 7775215B2 · Hassler, Jr. et al. · 2010 [cited by applicant]
US 7775966B2 · Dlugos et al. · 2010 [cited by applicant]
US 7850006B2 · Uchiyama · 2010 [cited by applicant]
US 7873401B2 · Shachar · 2011 [cited by applicant]
US 7887516B2 · Young · 2011 [cited by applicant]
US 7927270B2 · Dlugos et al. · 2011 [cited by applicant]
US 8016744B2 · Dlugos et al. · 2011 [cited by applicant]
US 8016745B2 · Hassler, Jr. et al. · 2011 [cited by applicant]
US 8174346B1 · Koren · 2012 [cited by applicant]
US 8240211B2 · Zeitner et al. · 2012 [cited by applicant]
US 8388541B2 · Messerly et al. · 2013 [cited by applicant]
US 8475407B2 · Kalpin et al. · 2013 [cited by applicant]
US 8483802B2 · Kalpin et al. · 2013 [cited by applicant]
US 8532743B2 · Stangenes et al. · 2013 [cited by applicant]
US 8622975B2 · Andreoni et al. · 2014 [cited by applicant]
US 8725435B2 · Snow et al. · 2014 [cited by applicant]
US 8781555B2 · Burnside et al. · 2014 [cited by applicant]
US 8840541B2 · Snow et al. · 2014 [cited by applicant]
US 8849382B2 · Cox et al. · 2014 [cited by applicant]
US 8939888B2 · Augarten et al. · 2015 [cited by applicant]
US 9017283B2 · Birchard et al. · 2015 [cited by applicant]
US 9113812B2 · Kalpin et al. · 2015 [cited by applicant]
US 9155517B2 · Dunbar et al. · 2015 [cited by applicant]
US 9216257B2 · Kalpin et al. · 2015 [cited by applicant]
US 9224529B2 · Gery · 2015 [cited by applicant]
US 9257220B2 · Nicholls et al. · 2016 [cited by applicant]
US 9299925B2 · Yi et al. · 2016 [cited by applicant]
US 9308022B2 · Chitre et al. · 2016 [cited by applicant]
US 9339601B2 · Kalpin et al. · 2016 [cited by applicant]
US 9439653B2 · Avneri et al. · 2016 [cited by applicant]
US 9456766B2 · Cox et al. · 2016 [cited by applicant]
US 9459087B2 · Dunbar et al. · 2016 [cited by applicant]
US 9492097B2 · Wilkes et al. · 2016 [cited by applicant]
US 9517299B2 · Tieck et al. · 2016 [cited by applicant]
US 9521961B2 · Silverstein et al. · 2016 [cited by applicant]
US 9554716B2 · Burnside et al. · 2017 [cited by applicant]
US 9597008B2 · Henkel et al. · 2017 [cited by applicant]
US 9636031B2 · Cox · 2017 [cited by applicant]
US 9649048B2 · Cox et al. · 2017 [cited by applicant]
US 9744291B2 · Tieck et al. · 2017 [cited by applicant]
US 10032552B2 · Ma et al. · 2018 [cited by applicant]
US 10449330B2 · Newman et al. · 2019 [cited by applicant]
US 10524691B2 · Newman et al. · 2020 [cited by applicant]
US 10751509B2 · Misener · 2020 [cited by applicant]
US 11344220B2 · Burkholz et al. · 2022 [cited by applicant]
US 11369410B2 · Lindekugel · 2022 [cited by applicant]
US 20030040671A1 · Somogyi et al. · 2003 [cited by applicant]
US 20030052785A1 · Gisselberg et al. · 2003 [cited by applicant]
US 20040019447A1 · Shachar · 2004 [cited by applicant]
US 20040051610A1 · Sajan · 2004 [cited by applicant]
US 20050059884A1 · Krag · 2005 [cited by applicant]
US 20060114088A1 · Shachar · 2006 [cited by applicant]
US 20060211914A1 · Hassler et al. · 2006 [cited by applicant]
US 20070244373A1 · Osypka · 2007 [cited by applicant]
US 20070290654A1 · Govari et al. · 2007 [cited by applicant]
US 20080049367A1 · Carson et al. · 2008 [cited by applicant]
US 20080146939A1 · McMorrow et al. · 2008 [cited by applicant]
US 20100043561A1 · Zeitner et al. · 2010 [cited by applicant]
US 20100096553A1 · Patil · 2010 [cited by examiner]
US 20100210950A1 · Dunbar et al. · 2010 [cited by applicant]
US 20110060185A1 · Ikuma et al. · 2011 [cited by applicant]
US 20110196235A1 · Dunbar et al. · 2011 [cited by applicant]
US 20110237936A1 · Kalpin et al. · 2011 [cited by applicant]
US 20110237937A1 · Kalpin et al. · 2011 [cited by applicant]
US 20130150714A1 · Howlett et al. · 2013 [cited by applicant]
US 20130296691A1 · Ashe · 2013 [cited by applicant]
US 20140031674A1 · Newman et al. · 2014 [cited by applicant]
US 20140165796A1 · Gauthier et al. · 2014 [cited by applicant]
US 20140253270A1 · Nicholls · 2014 [cited by examiner]
US 20140257080A1 · Dunbar et al. · 2014 [cited by applicant]
US 20140257104A1 · Dunbar et al. · 2014 [cited by applicant]
US 20140257746A1 · Dunbar et al. · 2014 [cited by applicant]
US 20150080710A1 · Henkel et al. · 2015 [cited by applicant]
US 20150359991A1 · Dunbar et al. · 2015 [cited by applicant]
US 20150365787A1 · Farrell · 2015 [cited by applicant]
US 20160015472A1 · Tiernan · 2016 [cited by examiner]
US 20160351312A1 · Koren · 2016 [cited by applicant]
US 20170007200A1 · Hagy et al. · 2017 [cited by applicant]
US 20170079548A1 · Silverstein et al. · 2017 [cited by applicant]
US 20170079549A1 · Henkel et al. · 2017 [cited by applicant]
US 20170079550A1 · Henkel et al. · 2017 [cited by applicant]
US 20170079551A1 · Henkel et al. · 2017 [cited by applicant]
US 20170126864A1 · Lim et al. · 2017 [cited by applicant]
US 20170261564A1 · Gabrys et al. · 2017 [cited by applicant]
US 20170325713A1 · Burkholz · 2017 [cited by examiner]
US 20170326342A1 · Ma et al. · 2017 [cited by applicant]
US 20180061546A1 · Ma et al. · 2018 [cited by applicant]
US 20180289929A1 · Ma · 2018 [cited by examiner]
US 20180310955A1 · Lindekugel · 2018 [cited by examiner]
US 20190298221A1 · Sonderegger · 2019 [cited by applicant]
US 20200360662A1 · Ma et al. · 2020 [cited by applicant]
US 20210065857A1 · Newman et al. · 2021 [cited by applicant]
US 20210169585A1 · Prince et al. · 2021 [cited by applicant]
US 20220105324A1 · Broniec et al. · 2022 [cited by applicant]
US 20220142501A1 · Prince et al. · 2022 [cited by applicant]
US 20220142502A1 · Prince et al. · 2022 [cited by applicant]
US 20220323101A1 · Lindekugel et al. · 2022 [cited by applicant]
US 20230006443A1 · Patankar et al. · 2023 [cited by applicant]
US 20240090793A1 · Prince et al. · 2024 [cited by applicant]
CN 105025787A · 2015 [cited by applicant]
CN 105232047A · 2016 [cited by applicant]
CN 103945772B · 2016 [cited by applicant]
CN 105073067B · 2017 [cited by applicant]
DE 102006033229B4 · 2013 [cited by applicant]
EP 2015105B1 · 2011 [cited by applicant]
EP 2730306A1 · 2014 [cited by applicant]
EP 2285287B1 · 2015 [cited by applicant]
EP 2939599A2 · 2015 [cited by applicant]
EP 2939601A2 · 2015 [cited by applicant]
EP 2997901A1 · 2016 [cited by applicant]
EP 2753243B1 · 2016 [cited by applicant]
JP 5349582B2 · 2013 [cited by applicant]
JP 5908981B2 · 2016 [cited by applicant]
JP 6242421B2 · 2017 [cited by applicant]
KR 20150123233A · 2015 [cited by applicant]
WO 2008009442A2 · 2008 [cited by applicant]
WO 2009010386A1 · 2009 [cited by applicant]
WO 2009129845A1 · 2009 [cited by applicant]
WO 2013034175A1 · 2013 [cited by applicant]
WO 2013142386A1 · 2013 [cited by applicant]
WO 2014062728A1 · 2014 [cited by applicant]
WO 2014135592A1 · 2014 [cited by applicant]
WO 16096190A1 · 2016 [cited by applicant]
WO 17016961A1 · 2017 [cited by applicant]
WO 2018201053A1 · 2018 [cited by applicant]
WO 2022099147A1 · 2022 [cited by applicant]
WO 2022103772A1 · 2022 [cited by applicant]
WO 2022271864A1 · 2022 [cited by applicant]
WO 2023009446A1 · 2023 [cited by applicant]
EP 18790656.5 filed Nov. 27, 2019 Supplementary European Search Report dated Apr. 9, 2020. [cited by applicant]
EP 221711096 filed May 2, 2022, Extended European Search Report dated Jul. 22, 2022. [cited by applicant]
EP20202521.9 filed Oct. 19, 2020 Extended European Search Report dated Jan. 28, 2021. [cited by applicant]
PCT/US2018/029958 filed Apr. 27, 2018 Communication Pursuant to Rules 70(2) and 70a(2) dated Apr. 29, 2020. [cited by applicant]
PCT/US2018/029958 filed Apr. 27, 2018 International Search Report and Written Opinion dated Jul. 11, 2018. [cited by applicant]
PCT/US2018/029958 filed Apr. 27, 2018 International Search Report dated Apr. 27, 2018. [cited by applicant]
PCT/US2021/058478 filed Nov. 8, 2021 International Search Report and Written Opinion dated Mar. 1, 2022. [cited by applicant]
U.S. Appl. No. 15/965,419, filed Apr. 27, 2018 Final Office Action dated Jan. 15, 2021. [cited by applicant]
U.S. Appl. No. 15/965,419, filed Apr. 27, 2018 Non-Final Office Action dated Aug. 6, 2021. [cited by applicant]
U.S. Appl. No. 15/965,419, filed Apr. 27, 2018 Non-Final Office Action dated Sep. 24, 2020. [cited by applicant]
U.S. Appl. No. 15/965,419, filed Apr. 27, 2018 Notice of Allowance dated Feb. 16, 2022. [cited by applicant]
PCT/US2021/058667 filed Nov. 9, 2021 International Search Report and Written Opinion dated Mar. 1, 2022. [cited by applicant]
PCT/US2022/034584 filed Jun. 22, 2022, International Preliminary Report on Patentability dated Dec. 14, 2023. [cited by applicant]
U.S. Appl. No. 17/521,680, filed Nov. 8, 2021 Non-Final Office Action dated Jun. 2, 2023. [cited by applicant]
U.S. Appl. No. 17/521,680, filed Nov. 8, 2021 Notice of Allowance dated Oct. 11, 2023. [cited by applicant]
U.S. Appl. No. 17/522,828, filed Nov. 9, 2021 Non-Final Office Action dated Nov. 9, 2023. [cited by applicant]
U.S. Appl. No. 17/850,468, filed Jun. 27, 2022 Restriction Requirement dated Dec. 29, 2023. [cited by applicant]
PCT/US2022/034584 filed Jun. 22, 2022, International Search Report and Written Opinion dated Oct. 10, 2022. [cited by applicant]
PCT/US2022/038202 filed Jul. 25, 2022 International Search Report and Written Opinion dated Nov. 14, 2022. [cited by applicant]
U.S. Appl. No. 17/522,828, filed Nov. 9, 2021 Notice of Allowance dated Apr. 3, 2024. [cited by applicant]
U.S. Appl. No. 17/850,468, filed Jun. 27, 2022 Notice of Allowance dated Sep. 5, 2024. [cited by applicant]
U.S. Appl. No. 17/872,814, filed Jul. 25, 2022 Non-Final Office Action dated Jul. 10, 2024. [cited by applicant]
U.S. Appl. No. 18/524,659, filed Nov. 30, 2023 Non-Final Office Action dated Jul. 29, 2024. [cited by applicant]
Cited By (1)
US 12,653,417